Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

July 6, 2020
Open Access

Circulating exosomal microRNA as potential biomarkers of hepatic injury and inflammation inGlycogen storage disease type 1a

Disease Models & Mechanisms
Roberta ResazAlessandra Eva
July 11, 2020

Targeting lactate production and efflux in prostate cancer

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Andreia Pereira-NunesFátima Baltazar
July 11, 2020

Metabolic signature of eyelid basal cell carcinoma

Experimental Eye Research
Jiancheng HuangJianhai Du
July 10, 2020
Review
Open Access

Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer

Non-coding RNA
Dominik A BarthMartin Pichler
July 11, 2020

PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer

Anti-cancer Drugs
Eric Achiborebador OkrahJing Gao
July 10, 2020

Circ_0000745 Promotes the Progression of Cervical Cancer by Regulating miR-409-3p/ATF1 Axis

Cancer Biotherapy & Radiopharmaceuticals
Xia CuiHuaji Shen
July 8, 2020

Nutrient Control of mRNA Translation

Annual Review of Nutrition
Xin Erica ShuShu-Bing Qian
July 11, 2020

Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: Results of a phase II clinical trial

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Shuhong WangHao Zhang
July 4, 2020

Glycolysis inhibition and apoptosis induction in human prostate cancer cells by FV-429-mediated regulation of AR-AKT-HK2 signaling network

Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
Xian ChenYuxin Zhou
July 12, 2020
Review

Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat

Signal Transduction and Targeted Therapy
Yang DongGuoliang Qing
July 9, 2020

Cancer Cell Metabolites: Updates on Current Tracing Methods

Chembiochem : a European Journal of Chemical Biology
Subashani Maniam, Sandra Maniam
July 4, 2020

Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts

Journal of Cancer Research and Clinical Oncology
Jing HuangLifen Zhang
July 8, 2020

Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective

Chemical Society Reviews
Jiyou HanJong Seung Kim

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.

© 2020 Meta ULC. All rights reserved
/feed-previews/cancer-metabolic-reprogramming/cfdc46a9-4e8a-4bb0-a0bd-ddf65173a8f4